cilengitide has been researched along with mk 2206 in 1 studies
Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) | Studies (mk 2206) | Trials (mk 2206) | Recent Studies (post-2010) (mk 2206) |
---|---|---|---|---|---|
194 | 29 | 133 | 355 | 28 | 347 |
Protein | Taxonomy | cilengitide (IC50) | mk 2206 (IC50) |
---|---|---|---|
RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 0.008 | |
RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 0.012 | |
RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 0.065 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Im, H; Lee, J; Ryu, KY; Yi, JY | 1 |
1 other study(ies) available for cilengitide and mk 2206
Article | Year |
---|---|
Integrin αvβ3-Akt signalling plays a role in radioresistance of melanoma.
Topics: Cell Line, Tumor; Cell Survival; Gamma Rays; Heterocyclic Compounds, 3-Ring; Humans; Integrin alphaVbeta3; Melanoma; Proto-Oncogene Proteins c-akt; Radiation Tolerance; Signal Transduction; Skin Neoplasms; Snake Venoms | 2020 |